190 related articles for article (PubMed ID: 34946593)
21. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
[TBL] [Abstract][Full Text] [Related]
22. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation.
Hu MJ; Shao XX; Li HZ; Nie WH; Wang JH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2018 Aug; 50(8):1111-1119. PubMed ID: 29770870
[TBL] [Abstract][Full Text] [Related]
23. Central relaxin-3 receptor (RXFP3) activation impairs social recognition and modulates ERK-phosphorylation in specific GABAergic amygdala neurons.
Albert-Gasco H; Sanchez-Sarasua S; Ma S; García-Díaz C; Gundlach AL; Sanchez-Perez AM; Olucha-Bordonau FE
Brain Struct Funct; 2019 Jan; 224(1):453-469. PubMed ID: 30368554
[TBL] [Abstract][Full Text] [Related]
24. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY
J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726
[TBL] [Abstract][Full Text] [Related]
25. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.
Ma S; Smith CM; Blasiak A; Gundlach AL
Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604
[TBL] [Abstract][Full Text] [Related]
26. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY
Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931
[TBL] [Abstract][Full Text] [Related]
27. Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor.
Wong LLL; Scott DJ; Hossain MA; Kaas Q; Rosengren KJ; Bathgate RAD
J Biol Chem; 2018 Oct; 293(41):15777-15789. PubMed ID: 30131340
[TBL] [Abstract][Full Text] [Related]
28. Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile.
Wilson KJ; Xiao J; Chen CZ; Huang Z; Agoulnik IU; Ferrer M; Southall N; Hu X; Zheng W; Xu X; Wang A; Myhr C; Barnaeva E; George ER; Agoulnik AI; Marugan JJ
Eur J Med Chem; 2018 Aug; 156():79-92. PubMed ID: 30006176
[TBL] [Abstract][Full Text] [Related]
29. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
[TBL] [Abstract][Full Text] [Related]
30. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4.
Ang SY; Hutchinson DS; Evans BA; Hossain MA; Patil N; Bathgate RA; Kocan M; Summers RJ
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):105-111. PubMed ID: 27888281
[TBL] [Abstract][Full Text] [Related]
31. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
[TBL] [Abstract][Full Text] [Related]
32. Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay.
Li HZ; Li N; Shao XX; Liu YL; Xu ZG; Guo ZY
Biochimie; 2020 Oct; 177():117-126. PubMed ID: 32810565
[TBL] [Abstract][Full Text] [Related]
33. Relaxin-3 receptor (RXFP3) activation in the nucleus of the solitary tract modulates respiratory rate and the arterial chemoreceptor reflex in rat.
Furuya WI; Dhingra RR; Gundlach AL; Hossain MA; Dutschmann M
Respir Physiol Neurobiol; 2020 Jan; 271():103310. PubMed ID: 31568840
[TBL] [Abstract][Full Text] [Related]
34. Engineering of chimeric peptides as antagonists for the G protein-coupled receptor, RXFP4.
Praveen P; Bathgate RAD; Hossain MA
Sci Rep; 2019 Nov; 9(1):17828. PubMed ID: 31780677
[TBL] [Abstract][Full Text] [Related]
35. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
[TBL] [Abstract][Full Text] [Related]
36. Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4.
Wu H; Handley TNG; Hoare BL; Hartono HA; Scott DJ; Chalmers DK; Bathgate RAD; Hossain MA
Biochem Pharmacol; 2024 Jun; 224():116239. PubMed ID: 38679208
[TBL] [Abstract][Full Text] [Related]
37. Receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
[TBL] [Abstract][Full Text] [Related]
38. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
[TBL] [Abstract][Full Text] [Related]
39. Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.
Xiao J; Huang Z; Chen CZ; Agoulnik IU; Southall N; Hu X; Jones RE; Ferrer M; Zheng W; Agoulnik AI; Marugan JJ
Nat Commun; 2013; 4():1953. PubMed ID: 23764525
[TBL] [Abstract][Full Text] [Related]
40. Hydrocarbon stapled B chain analogues of relaxin-3 retain biological activity.
Jayakody T; Marwari S; Lakshminarayanan R; Tan FC; Johannes CW; Dymock BW; Poulsen A; Herr DR; Dawe GS
Peptides; 2016 Oct; 84():44-57. PubMed ID: 27498038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
